194 related articles for article (PubMed ID: 6203834)
21. [Changes of complement in immune complex glomerulonephritis induced by cationized antigen].
Fukuda W; Takemura S; Yanagida K; Okamoto M; Kasamatsu Y; Deguchi M; Ueda M; Sugino S; Kondo M
Nihon Jinzo Gakkai Shi; 1989 Sep; 31(9):897-903. PubMed ID: 2531243
[TBL] [Abstract][Full Text] [Related]
22. Influence of antibody avidity on glomerular immune complex localization.
Iskandar SS; Jennette JC
Am J Pathol; 1983 Aug; 112(2):155-9. PubMed ID: 6224426
[TBL] [Abstract][Full Text] [Related]
23. Fate of immune complexes, glomerulonephritis, and cell-mediated vasculitis in lupus-prone MRL/Mp lpr/lpr mice.
Cruse JM; Lewis RE; Dilioglou S
Exp Mol Pathol; 2000 Dec; 69(3):211-22. PubMed ID: 11115362
[TBL] [Abstract][Full Text] [Related]
24. Studies on passive serum sickness. I. The glomerular fine structure of serum sickness nephritis induced by preformed antigen-antibody complexes in the mouse.
Okumura K; Kondo Y; Tada T
Lab Invest; 1971 May; 24(5):383-91. PubMed ID: 5088259
[No Abstract] [Full Text] [Related]
25. Antibody affinity and acute immune complex disease.
Griswold WR; Brams M
J Clin Lab Immunol; 1984 Aug; 14(4):181-3. PubMed ID: 6238168
[TBL] [Abstract][Full Text] [Related]
26. The effect of protein deficiency on the development of chronic antigen-antibody complex disease in mice.
Reinhardt MC; Devey M; Collins M; Gregory B; Steward MW
Clin Exp Immunol; 1981 Jun; 44(3):528-37. PubMed ID: 6459898
[TBL] [Abstract][Full Text] [Related]
27. Immune complex acute necrotizing glomerulonephritis with progression to diffuse glomerulosclerosis. A murine model.
Iskandar SS; Gifford DR; Emancipator SN
Lab Invest; 1988 Dec; 59(6):772-9. PubMed ID: 2974100
[TBL] [Abstract][Full Text] [Related]
28. Passive immune complex glomerulonephritis in mice: models for various lesions found in human disease. II. Low avidity complexes and diffuse proliferative glomerulonephritis with subepithelial deposits.
Germuth FG; Rodriguez E; Lorelle CA; Trump EI; Milano LL; Wise O
Lab Invest; 1979 Oct; 41(4):366-71. PubMed ID: 158675
[TBL] [Abstract][Full Text] [Related]
29. Relationship of the quality and quantity of circulating anti-BSA antibodies to the severity of glomerulonephritis in rats with chronic serum sickness.
Noble B; Steward MW; Vladutiu A; Brentjens JR
Clin Exp Immunol; 1987 Feb; 67(2):277-82. PubMed ID: 2955967
[TBL] [Abstract][Full Text] [Related]
30. Suppression of antibody synthesis by prostaglandin E as a mechanism for preventing murine immune complex glomerulonephritis.
McLeish KR; Gohara AF; Gunning WT
Lab Invest; 1982 Aug; 47(2):147-52. PubMed ID: 6213813
[TBL] [Abstract][Full Text] [Related]
31. Experimental immunologic glomerulonephritis.
Dixon FJ; Wilson CB; Marquardt H
Adv Nephrol Necker Hosp; 1971; 1():1-10. PubMed ID: 4283274
[No Abstract] [Full Text] [Related]
32. Influence of affinity and antigen density on antibody localization in a modifiable tumor targeting model.
Zuckier LS; Berkowitz EZ; Sattenberg RJ; Zhao QH; Deng HF; Scharff MD
Cancer Res; 2000 Dec; 60(24):7008-13. PubMed ID: 11156404
[TBL] [Abstract][Full Text] [Related]
33. A role for insoluble antibody-antigen complexes in glomerulonephritis?
Cameron JS; Clark WF
Clin Nephrol; 1982 Aug; 18(2):55-61. PubMed ID: 6216031
[No Abstract] [Full Text] [Related]
34. A murine nephritogenic monoclonal antibody binds to both single-stranded deoxyribonucleic acid and glomerulus.
Nagata N; Miyashima S; Taketani S; Toki J; Hosaka N; Tomita T; Fujishima H; Tokunaga R; Ikehara S
Lab Invest; 1994 Nov; 71(5):765-72. PubMed ID: 7967527
[TBL] [Abstract][Full Text] [Related]
35. Interaction of rheumatoid factor with immune complexes in experimental glomerulonephritis--possible role of antiglobulins in chronicity.
Ford PM
J Rheumatol Suppl; 1983 Dec; 11():81-4. PubMed ID: 6230448
[TBL] [Abstract][Full Text] [Related]
36. Removal of glomerular immune complex deposits by excess antigen in chronic mouse model of immune complex disease.
Haakenstad AO; Striker GE; Mannik M
Lab Invest; 1983 Mar; 48(3):323-31. PubMed ID: 6219249
[No Abstract] [Full Text] [Related]
37. Prevention of experimental immune complex glomerulonephritis by specific inactivation of immunoreactive cells.
Dienes HP; Filipp G; Thoenes W; Biro G; Schumacher H; Kiesmann W; Lehmann G
Allergol Immunopathol (Madr); 1985; 13(2):151-6. PubMed ID: 2408456
[TBL] [Abstract][Full Text] [Related]
38. Experimental IgA nephropathy. Enhanced deposition of glomerular IgA immune complex in proteinuric states.
Chen A; Ding SL; Sheu LF; Song YB; Shieh SD; Shaio MF; Chou WY; Ho YS
Lab Invest; 1994 May; 70(5):639-47. PubMed ID: 8196360
[TBL] [Abstract][Full Text] [Related]
39. In situ immune complex formation in the mouse glomerulus: reactivity with human IgM rheumatoid factor and the effect on subsequent immune complex deposition.
Ford PM; Kosatka I
Clin Exp Immunol; 1983 Feb; 51(2):285-91. PubMed ID: 6340871
[TBL] [Abstract][Full Text] [Related]
40. Passive immune complex glomerulonephritis in mice: models for various lesions found in human disease. I. High avidity complexes and mesangiopathic glomerulonephritis.
Germuth FG; Rodriguez E; Lorelle CA; Trump EI; Milano L; Wise O
Lab Invest; 1979 Oct; 41(4):360-5. PubMed ID: 158674
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
